Background: Because the natural history of atrial tachyarrhythmia (AT) is not known in patients with implantable cardioverter-defibrillators (ICDs) but without device-based atrial therapies, we aimed ...

Placement of an implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual clinical care -- although a ...

Medtronic (NYSE: MDT) today announced new data supporting its Aurora and OmniaSecure defibrillation technology offerings.

NEW ORLEANS, Nov. 9 – A small study of patients with heart failure not caused by blocked arteries indicates that women, as well as men, may benefit from implantable cardioverter-defibrillators (ICD) ...

ICD recipients who do not meet guideline criteria have elevated risk for adverse outcomes. Medical decision making is under increased scrutiny, particularly when it involves the use of costly ...

Routine placement of atrial leads is common during implantable cardioverter-defibrillator (ICD) implantation for primary prevention despite guidelines that discourage it—now there are new ...

Please provide your email address to receive an email when new articles are posted on . Researchers have developed a risk model to help predict the chances of adverse events after a patient receives ...

"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...

The FDA today approved the Subcutaneous Implantable Defibrillator (S-ICD) system from Cameron Health. The device is the first ICD that does not require a lead that connects directly to the heart and ...

(HealthDay News) – A simple model may be used to predict risk for in-hospital adverse events among patients receiving an implantable cardioverter defibrillator (ICD), according to research published ...

This article explores pacemaker and ICD system architecture, with a focus on connector types and interconnect technologies.

Rome, Italy - 28 August, 2016: Placement of an implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual ...